Remi Martin-Fardon

Affiliations: 
Scripps Research Institute, La Jolla, La Jolla, CA, United States 
Google:
"Remi Martin-Fardon"
Mean distance: 14.81 (cluster 19)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Matzeu A, Martin-Fardon R. (2022) Understanding the Role of Orexin Neuropeptides in Drug Addiction: Preclinical Studies and Translational Value. Frontiers in Behavioral Neuroscience. 15: 787595
Laque A, Wagner GE, Matzeu A, et al. (2022) Linking drug and food addiction via compulsive appetite. British Journal of Pharmacology
Matzeu A, Martin-Fardon R. (2021) Blockade of corticotropin-releasing factor receptor 1 in the central amygdala prevents cocaine-seeking behaviour induced by orexin-A administered to the posterior paraventricular nucleus of the thalamus in male rats. Journal of Psychiatry & Neuroscience : Jpn. 46: E459-E471
Matzeu A, Martin-Fardon R. (2021) Cocaine-Seeking Behavior Induced by Orexin A Administration in the Posterior Paraventricular Nucleus of the Thalamus Is Not Long-Lasting: Neuroadaptation of the Orexin System During Cocaine Abstinence. Frontiers in Behavioral Neuroscience. 15: 620868
Matzeu A, Martin-Fardon R. (2020) Blockade of Orexin Receptors in the Posterior Paraventricular Nucleus of the Thalamus Prevents Stress-Induced Reinstatement of Reward-Seeking Behavior in Rats With a History of Ethanol Dependence. Frontiers in Integrative Neuroscience. 14: 599710
Pavon FJ, Polis I, Stouffer DG, et al. (2020) COX-2 Inhibition Antagonizes Intra-Accumbens 2-Arachidonoylglycerol-Mediated Reduction in Ethanol Self-Administration in Rats. Alcoholism, Clinical and Experimental Research
Matzeu A, Martin-Fardon R. (2020) Targeting the Orexin System for Prescription Opioid Use Disorder. Brain Sciences. 10
Matzeu A, Martin-Fardon R. (2019) Targeting the orexin system for prescription opioid use disorder: Orexin-1 receptor blockade prevents oxycodone taking and seeking in rats. Neuropharmacology. 164: 107906
Suárez J, Khom S, Alén F, et al. (2019) Cessation of fluoxetine treatment increases alcohol seeking during relapse and dysregulates endocannabinoid and glutamatergic signaling in the central amygdala. Addiction Biology. e12813
Matzeu A, Terenius L, Martin-Fardon R. (2018) Exploring Sex Differences in the Attenuation of Ethanol Drinking by Naltrexone in Dependent Rats During Early and Protracted Abstinence. Alcoholism, Clinical and Experimental Research
See more...